tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Potential of SCY-247: A Game-Changer in Antifungal Treatment
PremiumRatingsPromising Potential of SCY-247: A Game-Changer in Antifungal Treatment
2M ago
Scynexis announces presentations highlighting data on SCY-247
Premium
The Fly
Scynexis announces presentations highlighting data on SCY-247
2M ago
Optimistic Outlook on SCYNEXIS: Strategic Developments and Financial Health Drive Buy Rating
Premium
Ratings
Optimistic Outlook on SCYNEXIS: Strategic Developments and Financial Health Drive Buy Rating
2M ago
SCYNEXIS: Positive Developments and Financial Stability Justify Buy Rating
PremiumRatingsSCYNEXIS: Positive Developments and Financial Stability Justify Buy Rating
5M ago
Scynexis resumes patient dosing in Phase 3 MARIO study
Premium
The Fly
Scynexis resumes patient dosing in Phase 3 MARIO study
5M ago
SCYNEXIS: Buy Rating Affirmed Amid Strategic Advancements and Promising Antifungal Innovations
Premium
Ratings
SCYNEXIS: Buy Rating Affirmed Amid Strategic Advancements and Promising Antifungal Innovations
5M ago
Scynexis to present preclinical data on SCY-247 at ESCMID Meeting
PremiumThe FlyScynexis to present preclinical data on SCY-247 at ESCMID Meeting
7M ago
SCYNEXIS Reports 2024 Financial Results and Updates
Premium
Company Announcements
SCYNEXIS Reports 2024 Financial Results and Updates
8M ago
Scynexis initiates dosing in Phase 1 trial of SCY-247
Premium
The Fly
Scynexis initiates dosing in Phase 1 trial of SCY-247
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100